Episurf Medical Gains FDA Approval for IDE Study

Episurf Medical received FDA approval for its Investigational Device Exemption (IDE) application to initiate a clinical trial of the Episealer® knee implant. The two-year prospective, randomized, controlled, multi-center study will evaluate the device vs. microfracture in the treatment of focal femoral knee chondral or osteochondral lesions in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us